×
×
×
×
×

Tell us once and we'll remember.

I'm an...

Don't worry, you can always change this selection using the icons at the top left of the site.
  

The Diabetes and Obesity Market Opportunity

July 6, 2023

 

Health care analysts Marshall Gordon and Brittany Henderson join Jeff Schulze to highlight new treatments for the chronic conditions of diabetes and obesity. They quantify the size of the Type 1 and Type 2 diabetes and obesity markets, discuss innovations in managing diabetes and explain how GLP-1 therapeutics developed to treat diabetes can be effective in addressing the much larger obese population.

Related Perspectives

Disciplined Approach to AI Provides Resilience
Large Cap Growth 3Q26: The Strategy’s focus on quality and valuation proved beneficial in a volatile period for higher beta growth stocks.
Refining Growth Exposures Through Tech Volatility
International Growth ADR 3Q26: To balance our higher-beta AI holdings, we broadened our structural growth exposure and repurchased several previously held secular growers at oversold levels.
Perfect Storm Weighs on AI Infrastructure
International Growth EAFE 3Q26: We view the growth selloff as sentiment-driven rather than fundamental and remain committed to the secular AI trend with extra attention to risk.
Large Cap Growth Monthly Update
Large Cap Growth August 2026: The Strategy outperformed, driven by strong stock selection across communication services, industrials, health care and information technology.
Tailwinds Forming for Health Care
Podcast: Improved biopharma funding is proving beneficial to CROs and life science tools companies while patent expirations are separating pharmaceuticals.
More
  • Past performance is no guarantee of future results. Copyright © 2023 ClearBridge Investments. All opinions and data included in this commentary are as of the publication date and are subject to change. The opinions and views expressed herein are of the author and may differ from other portfolio managers or the firm as a whole, and are not intended to be a forecast of future events, a guarantee of future results or investment advice. This information should not be used as the sole basis to make any investment decision. The statistics have been obtained from sources believed to be reliable, but the accuracy and completeness of this information cannot be guaranteed. Neither ClearBridge Investments, LLC  nor its information providers are responsible for any damages or losses arising from any use of this information.

more